PET imaging for suspected brain tumors
Part of Cancer clinical trials.
This study tests a special imaging method to look at brain tumors before surgery. It uses a tracer that may help doctors see tumors more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years old or older
- You are scheduled for surgery for a possible brain tumor
- You can understand and sign the consent form on your own
- You do not have serious liver or kidney problems
- You are not allergic to the imaging dye or tracer
- You can lie still for about 30–60 minutes for the scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.